Better Therapeutics (Nasdaq:BTTX) announced today that it appointed Frank Karbe as its new president and CEO.
San Francisco-based Better Therapeutics develops prescription digital therapeutics (PDTs) based on nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases.
Get the full story at our sister site, Drug Delivery Business News.